$1.6 Billion is the total value of Novo Holdings A/S's 48 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SYK | STRYKER CORPORATION | $194,844,105 | +20.7% | 796,941 | 0.0% | 12.16% | +58.1% | |
| ASML | ASML HOLDING N V | $123,907,128 | +31.6% | 226,770 | 0.0% | 7.74% | +72.3% | |
| STE | STERIS PLC | $86,377,112 | +11.1% | 467,687 | 0.0% | 5.39% | +45.4% | |
| CRM | SALESFORCE.COM, INC. | $76,703,315 | -7.8% | 578,500 | 0.0% | 4.79% | +20.7% | |
| CTLT | CATALENT INC | $73,495,839 | -37.8% | 1,632,878 | 0.0% | 4.59% | -18.5% | |
| BAM | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $71,928,156 | -29.9% | 2,508,830 | 0.0% | 4.49% | -8.2% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $54,281,025 | -9.1% | 6,071,703 | 0.0% | 3.39% | +19.0% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $52,946,002 | +8.6% | 710,780 | 0.0% | 3.31% | +42.3% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $44,117,850 | +10.1% | 500,827 | 0.0% | 2.76% | +44.2% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $32,841,764 | -7.2% | 1,684,193 | 0.0% | 2.05% | +21.5% | |
| VECT | VECTIVBIO HLDG AG | $28,919,931 | +44.3% | 3,339,484 | 0.0% | 1.81% | +89.1% | |
| VERV | VERVE THERAPEUTICS INC | $17,629,998 | -43.7% | 911,111 | 0.0% | 1.10% | -26.2% | |
| SILK | SILK RD MED INC | $14,560,756 | +17.4% | 275,511 | 0.0% | 0.91% | +53.8% | |
| LVTX | LAVA THERAPEUTICS NV | $11,645,592 | -23.4% | 3,327,312 | 0.0% | 0.73% | +0.3% | |
| ABCL | ABCELLERA BIOLOGICS INC | $11,415,649 | +2.4% | 1,126,915 | 0.0% | 0.71% | +34.3% | |
| RPHM | RENEO PHARMACEUTICALS INC | $7,992,778 | -30.4% | 3,430,377 | 0.0% | 0.50% | -8.9% | |
| IO BIOTECH INC | $7,539,244 | -15.1% | 3,277,932 | 0.0% | 0.47% | +11.1% | ||
| CYT | CYTEIR THERAPEUTICS INC | $6,501,681 | -14.1% | 3,940,413 | 0.0% | 0.41% | +12.5% | |
| KNTE | KINNATE BIOPHARMA INC | $4,975,813 | -49.0% | 815,707 | 0.0% | 0.31% | -33.1% | |
| SPRB | SPRUCE BIOSCIENCES INC | $4,952,227 | -19.9% | 4,514,336 | 0.0% | 0.31% | +4.7% | |
| LUNG | PULMONX CORP | $4,303,979 | -49.4% | 510,555 | 0.0% | 0.27% | -33.7% | |
| GRTX | GALERA THERAPEUTICS INC | $3,663,941 | -14.4% | 2,459,021 | 0.0% | 0.23% | +12.3% | |
| GLTO | GALECTO INC | $2,872,460 | -39.2% | 2,497,791 | 0.0% | 0.18% | -20.4% | |
| MQ | MARQETA INC | $2,697,919 | -14.2% | 441,558 | 0.0% | 0.17% | +12.0% | |
| SPRO | SPERO THERAPEUTICS INC | $811,200 | -13.5% | 468,902 | 0.0% | 0.05% | +13.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.